Henry Nordhoff
Member
Advisory Board
GenScript
Switzerland
Biography
Henery Nordhoff served as President and CEO of Gen-Probe Inc. for fifteen years until his retirement in May 2009, while he remains as the Chairman. Prior to joining Gen-Probe Inc., Mr. Nordhoff served as President and CEO of TargeTech, Inc., a gene therapy company focused on the treatment of inherited diseases, which was merged into the Immune Response Corporation in 1992. Previously, Nordhoff spent over 16 years at Pfizer Inc. where he held several senior positions in Brussels, Seoul, Tokyo and New York. Mr. Nordhoff is Vice Chairman of the Shipston Group, and leads the private equity firm’s healthcare investments in Asia. Mr. Nordhoff serves on the Board of Directors of the Prostate Cancer Foundation, MannKind Corporation and the San Diego Museum of Art. He is a member of the Advisory Committees of the UCSD School of Business Administration, the Jacobs School of Engineering at UCSD, the Rady School of Management at UCSD, and the International Advisory Board for Chugai Pharmaceutical Co., Ltd. of Tokyo. He is a member of the Founders Committee at the Preuss School and is a past Chairman of the California Healthcare Institute and the San Diego Regional Economic Corporation. Henry Nordhoff received his Bachelor of Arts degree in International Relations and Political Economy from Johns Hopkins University and earned a Master's degree in International Business and Finance from Columbia University.
Research Interest
Biochemistry , Pharmacology and Chemotherapy, business management
